By any other name: ambiguity in marketing proprietary anti-infective agents.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 17143817.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In 55 instances, a single proprietary (trade) name has been used to market > or = 2 distinct generic anti-infective agents. In some cases, one trade name represents 2 different drugs in the same country--or even marketed by the same manufacturer. Some unrelated drugs and poisonous substances are also manufactured under trade names assigned to anti-infectives. The use of proprietary names in the prescribing of anti-infective drugs could result in considerable confusion or harm to patients.
Medical subject headings
- Anti-Infective Agents
- Drugs, Generic
- Marketing
- Pharmaceutical Preparations
- Terminology as Topic